Dr. Li Hao is Senior Director and Head of Next-Generation Sequencing and Data Sciences in Pfizer Vaccine R&D, a recognized scientific and strategic leader working at the intersection of vaccine science, data and AI. Her current focus is advancing AI-enabled vaccine research by establishing robust AI-ready data ecosystems, modernizing pathogen surveillance, and translating emerging AI/ML capabilities into applications across antigen discovery, immunogenicity prediction, and vaccine design.
Over more than a decade at Pfizer, Dr. Hao has led multidisciplinary teams applying genomics, multi-omics, computational biology, and data science to complex challenges across vaccine R&D. She served as bioinformatics lead supporting major clinical and regulatory milestones, including the licensure of Trumenba and Paxlovid. Under her guidance, the NGS & data sciences team currently powers a diverse portfolio of bacterial and viral pathogen programs spanning early discovery through clinical development.
Dr. Hao received her Ph.D. in Evolutionary Genetics from Pennsylvania State University and B.S. in Genetics & Genetic Engineering from Fudan University, with postdoctoral training in human genomics and systems biology at Johns Hopkins University and NYU Langone Medical Center.